Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia

Published:2024-05 Issue:5 Volume:30 Page:430-440
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Lee Tsung-Ying¹,Johnson Abree¹,Cooke Catherine E.¹,Yared Jean A.²,Summers Amanda¹,Yang Keri³,Liu Sizhu³⁴,Tang Boxiong³⁵,Onukwugha Eberechukwu¹

Affiliation:

1. Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland, Baltimore.

2. Department of Medicine, School of Medicine, University of Maryland, Baltimore.

3. BeiGene USA, Inc., San Mateo, CA.

4. GlaxoSmithKline, Philadelphia, PA.

5. Agenus, Lexington, MA.

Publisher

Academy of Managed Care Pharmacy

Reference10 articles.

1. Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

2. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States

3. Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy

4. Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia

5. Differences in Treatment Patterns and Health Care Costs among Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Patients Receiving Rituximab in the Hospital Outpatient Setting versus the Office/Clinic Setting

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3